Related Experiment Videos
Boswellic acids in chronic inflammatory diseases
1Dept. of Pharmacology, Institute of Pharmaceutical Sciences, University of Tuebingen, Tuebingen, Germany. sekretariat.ammon@uni-tuebingen.de
Planta Medica
|October 7, 2006
Summary
Boswellia oleogum resins exhibit anti-inflammatory effects by inhibiting 5-lipoxygenase and modulating immune components. Clinical studies suggest potential benefits for autoimmune diseases with fewer side effects than conventional treatments.
Area of Science:
- Phytochemistry
- Immunology
- Pharmacology
Background:
- Oleogum resins from Boswellia species are integral to traditional Indian and African medicine.
- These resins are employed for managing a diverse range of ailments.
- Preliminary animal studies indicate significant anti-inflammatory properties.
Purpose of the Study:
- To investigate the anti-inflammatory mechanisms of Boswellia oleogum resins.
- To explore the potential therapeutic applications in autoimmune diseases.
- To compare the safety and efficacy profile with existing treatments.
Main Methods:
- In vitro and in vivo models to assess anti-inflammatory activity.
- Analysis of specific boswellic acids and their biochemical targets.
- Evaluation of effects on immune system components like cytokines and complement.
- Pilot clinical trials in patients with autoimmune conditions.
Main Results:
- Boswellia extracts demonstrate anti-inflammatory activity distinct from NSAIDs.
- Inhibition of 5-lipoxygenase is a primary mechanism.
- Modulation of cytokines (interleukins, TNF-alpha), complement system, leukocyte elastase, and oxygen radicals are implicated.
- Pilot studies show promise for rheumatoid arthritis, Crohn's disease, ulcerative colitis, and asthma.
Conclusions:
- Boswellia resins possess unique anti-inflammatory properties targeting key immune pathways.
- Evidence suggests potential as a treatment for autoimmune disorders.
- Favorable side effect profile compared to conventional therapies warrants further investigation.
Related Concept Videos
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...